Discovery of a new class of integrin antibodies for fibrosis
Ji Zhang(Merck & Co., Inc., Rahway, NJ, USA (United States)), Masahisa Handa(Merck & Co., Inc., Rahway, NJ, USA (United States))
Cited by 68
Related Papers
Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response
|Nature Cancer|2023|219
Identification of Novel Carbocyclic Pyrimidine Cyclic Dinucleotide STING Agonists for Antitumor Immunotherapy Using Systemic Intravenous Route
|Journal of Medicinal Chemistry|2021|42